Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
(NY:
KVUE
)
18.53
-0.31 (-1.65%)
Official Closing Price
Updated: 7:00 PM EDT, Jun 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about KVUE
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
3 Warren Buffett Stocks to Buy (and Never Sell)
June 01, 2023
Investors who are looking for safe retirement stocks often turn to Warren Buffett's portfolio to get a sense of which stocks to buy.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For June 1, 2023
June 01, 2023
Via
Benzinga
Kenvue Stock Up 5.37% Since IPO
May 05, 2023
Via
Benzinga
Kenvue's Growth Forecast: Exploring The Future Of Johnson & Johnson's Carve-Out
May 30, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 30, 2023
May 30, 2023
Via
Benzinga
7 Consumer Stocks to Buy and Hold for the Long Haul
May 29, 2023
For steady dividends and price appreciation, consider adding these seven best long-term consumer stocks to your portfolio.
Via
InvestorPlace
3 Dow Stocks Poised for a Roaring Relief Rally
May 26, 2023
Here are some compelling Dow stocks to buy if you believe the market may be on the cusp of a relief rally this summer.
Via
InvestorPlace
Got $1,000? 5 Buffett Stocks to Buy and Hold Forever
May 21, 2023
Warren Buffett owns many stocks, but these five have solid growth potential.
Via
The Motley Fool
Kenvue Just IPO'd, but Is the Stock a Buy?
May 19, 2023
The Johnson & Johnson spinoff is worth considering, but it's not a must-buy.
Via
The Motley Fool
2 Dividend Stocks to Double Up On Right Now
May 17, 2023
These dividend stocks look attractive right now.
Via
The Motley Fool
Kenvue Has Gone Public: Should You Buy the Stock?
May 16, 2023
Its business could be resistant to the effects of inflation.
Via
The Motley Fool
Which Is the Better Forever Stock: Johnson & Johnson or UnitedHealth Group?
May 16, 2023
Both stocks have built-in economic diversity and are solid long-term investments.
Via
The Motley Fool
2 No-Brainer Healthcare Stocks to Buy Right Now
May 13, 2023
Boring businesses can make for beautiful lifelong holdings -- these two stocks show us why.
Via
The Motley Fool
How Apple Pleased Investors
May 12, 2023
We've got a lot of ground to cover as company earnings reports continue to flood in.
Via
The Motley Fool
7 Overvalued Stocks to Sell for May 2023
May 12, 2023
It's easy to fall into the trap of getting overvalued stocks. What may have been a great buy a year ago could be overvalued today.
Via
InvestorPlace
2 Warren Buffett Stocks to Buy Hand Over Fist in May
May 11, 2023
These two Berkshire Hathaway holdings are solid picks in May.
Via
The Motley Fool
Does Johnson & Johnson's Kenvue Spinoff Make Sense?
May 08, 2023
We also look at Darden Restaurants' acquisition and Yum! Brands' quarter.
Via
The Motley Fool
These 2 Top Stocks Just Declared Dividend Raises
May 08, 2023
These companies manage to keep growing and generating excess profits, which is admirable given their age and size.
Via
The Motley Fool
J&J's Kenvue Jumps 20% In Market Debut
May 07, 2023
Shares of Johnson & Johnson's consumer-health spin-off Kenvue soared 20% in their market debut on Thursday, making it the biggest U.S. IPO in over a year. Under Kenvue's umbrella are widely-known...
Via
Talk Markets
3 Great Income Stocks That Retirees Should Love
May 06, 2023
If you're looking for additional retirement income, these three stocks should be right up your alley.
Via
The Motley Fool
S&P 500 Finishes Strong Following Wild Week Of Bank Stock Volatility
May 05, 2023
The Fed's tenth consecutive interest rate hike, the buyout of First Republic's assets by JPMorgan Chase & Co (NYSE: JPM) and a hot April jobs report gave investors plenty to digest this week.
Via
Benzinga
Acelyrin Raises $540M In IPO, Stock Gains Over 20% In Trading Debut
May 05, 2023
Acelyrin Inc (NASDAQ: SLRN), a late-stage clinical biopharma company, started trading today and opened at $23/share compared to IPO
Via
Benzinga
Which Healthcare Stock Is a Compelling Pick for the Long Haul?
May 04, 2023
Healthcare stocks are especially resilient in times of uncertainty. Let's take a look at three compelling picks.
Via
InvestorPlace
SLRN Stock IPO: When Does Acelyrin Go Public? What Is the Acelyrin IPO Price Range?
May 04, 2023
Here's what prospective investors in Acelyrin and SLRN stock may want to watch out for as the company gears up for its IPO.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.